Latest financial market updates and expert analysis
Analysis Shares of AbCellera Biologics rocketed more than 33% in Monday trading after the biotech unveiled Phase-2 data showing its experimental antibody ABCL635 delivered a dramatic reduction in menopausal hot flashes...
The numbers coming out of BYD’s Shenzhen headquarters look impressive on the surface. July wholesale deliveries of New Energy Vehicles...
The narrative around Almonty Industries has shifted from development promise to production reality, and investors are positioning accordingly. With the...
The curtain rises on Rocket Lab USA’s second-quarter results Monday after the closing bell, with the conference call scheduled for...
The most striking thing about Microsoft’s late-July earnings report isn’t the headline numbers — it’s the gap between what the...
When Michael Burry publicly declared Nebius Group a “fish in a barrel,” he didn’t just make a contrarian statement —...
The contrast could hardly be starker. On one side, Xiaomi is firing off product announcements across tablets, smartphones, and electric...
The biotech playbook often reads like a study in delayed gratification, and Replimune Group just authored its own chapter. After...
The weekend quiet at the Frankfurt exchange offers little comfort for Vonovia shareholders. The stock closed Friday at €21.07, a...
The arithmetic at Nvidia is becoming harder to reconcile. Over the past three months, company insiders have sold roughly $767.2...
The numbers coming out of Micron Technology this year read like something from a different era of semiconductor history. The...
